For example, delivering CRISPR-dCas9 based DNA methylation editing tools to midbrain substantia nigra dopaminergic neurons through lentivirus can successfully regulate the expression of SNCA genes, reduce the aggregation of α-synuclein, and provide a potential therapeutic approach for Parkinson’s disease. The gene discussed is SNCA; the disease is Parkinson disease.